Evidence map›Paper›PMID 30166452›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction.

Svenja Hinrichs, Katharina Scherschel, Saskia Krüger, Johannes Tobias Neumann, Michael Schwarzl, Isabell Yan, Svenja Warnke, Francisco M Ojeda, Tanja Zeller, Mahir Karakas and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biomarker-Guided Individualization of Antibiotic Therapy.Clinical pharmacology and therapeutics · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Svenja HinrichsClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Katharina ScherschelPartner Site Hamburg/Kiel/Lübeck, German Center for Cardiovascular Research, 20246 Hamburg, Germany.
Saskia KrügerClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.ORCID 0000-0002-0807-4851
Johannes Tobias NeumannClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Michael SchwarzlClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Isabell YanClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Svenja WarnkeClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Francisco M OjedaClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Tanja ZellerClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Mahir KarakasClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Till KellerDivision of Cardiology, Department of Medicine III, Goethe University Frankfurt, 60598 Frankfurt, Germany.
Christian MeyerPartner Site Hamburg/Kiel/Lübeck, German Center for Cardiovascular Research, 20246 Hamburg, Germany.
Stefan BlankenbergClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Dirk WestermannClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany.
Diana LindnerClinic for General and Interventional Cardiology, University Heart Center Hamburg, 20246 Hamburg, Germany; d.lindner@uke.de.
Universität Hamburg · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased adrenomedullin (ADM) levels are associated with various cardiac diseases such as myocardial infarction (MI). ADM is cleaved off from the full-length precursor protein proadrenomedullin (ProADM) during its posttranslational processing. To date, no biological effect of ProADM is reported, while ADM infusion leads to antiapoptotic effects and improved cardiac function. Using an MI mouse model, we found an induction of ProADM gene as well as protein expression during the early phase of MI. This was accompanied by apoptosis and increasing inflammation, which substantially influence the post-MI remodeling processes. Simulating ischemia in vitro, we demonstrate that ProADM expression was increased in cardiomyocytes and cardiac fibroblasts. Subsequently, we treated ischemic cardiomyocytes with either ProADM or ADM and found that both proteins increased survival. This effect was diminishable by blocking the ADM

Indexed as

AdrenomedullinAgedAnimalsApoptosisCells, CulturedCytokinesFemaleGene ExpressionHumansInflammationInflammation MediatorsMaleMice, Inbred C57BLMiddle AgedMyocardial InfarctionMyocytes, CardiacAdrenomedullinCytokinesInflammation MediatorsproadrenomedullinProtein Precursorsadrenomedullincardioprotectionischemiamyocardial infarctionproadrenomedullin

Identifiers

PMID30166452
PMCPMC6140510
OpenAlexW2889171708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.